Clinical Trial Update: Oxytocin Treatment of Alcohol Dependence [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating oxytocin for alcohol dependence and withdrawal completed; results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• Alcohol Withdrawal

Drugs mentioned

• Oxytocin (Oxytocin)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Alcohol Withdrawal, Alcohol Dependence | Phase 2 | Status: COMPLETED | Results posted: 2017-04-04